![glp 1 monoclonal antibody Anti-GLP-1 [4F3] (ab23472) Invitrogen™ GLP-1 Monoclonal Antibody (4)](https://content.abcam.com/products/images/glp-1-antibody-4f3-ab23472--immunohistochemistry-formalin-pfa-fixed-paraffin-embedded-sections-img116323.jpg)
glp 1 monoclonal antibody Anti-GLP-1 [4F3] (ab23472) Invitrogen™ GLP-1 Monoclonal Antibody (4)
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Habegger K.M., Stemmer K., Cheng C., Muller T.D., Heppner K.M., Ottaway N
![glp 1 monoclonal antibody Anti-GLP-1 [4F3] (ab23472) Invitrogen GLP-1 Monoclonal Antibody (4)](https://assets.fishersci.com/TFS-Assets/LSG/antibodies/ABS-033-04-02-GLP1-IHC_20200813102324.jpg-650.jpg)
Emerging Role of Dual GLP-1 Receptor Agonists
![glp 1 monoclonal antibody Anti-GLP-1 [4F3] (ab23472) Invitrogen GLP-1 Monoclonal Antibody (4)](https://assets.fishersci.com/TFS-Assets/BID/product-images/primary-antibody-image.jpg-650.jpg)
Case reports
![glp 1 monoclonal antibody Anti-GLP-1 [4F3] (ab23472) Invitrogen GLP-1 Monoclonal Antibody (4)](https://www.biomatik.com/content/product_data_images/Antibody.jpg)
There were no signs of orbitopathy or pretibial myxedema
![glp 1 monoclonal antibody Anti-GLP-1 [4F3] (ab23472) Invitrogen GLP-1 Monoclonal Antibody (4)](https://content.abcam.com/products/images/glp-1r-antibody-epr21819-ab218532--immunohistochemistry-frozen-sections-img34413.jpg)
This difference in structure is significant because it affects how the body processes allulose
![glp 1 monoclonal antibody Anti-GLP-1 [4F3] (ab23472) Invitrogen GLP-1 Monoclonal Antibody (4)](https://assets.fishersci.com/TFS-Assets/LSG/figures/ABS046-03.jpg-650.jpg)
